UNSPSC 51322000: Antihyperlipidemic and hypocholesterolemic amines

Antihyperlipidemic and hypocholesterolemic drugs a group of compounds derived from ammonia by substituting organic radicals for the hydrogens.

UNSPSC 51322000 Antihyperlipidemic and hypocholesterolemic amines is a Class code covering the procurement of cardiovascular and antiarrhythmic medications by state and local health agencies, emergency services, and pharmacy benefit programs. Recent state and local activity shows broader pharmaceutical procurement extending beyond the code's nominal scope to include emergency life support medications (epinephrine, adenosine, diltiazem, labetalol) supplied to fire rescue services and generic multi-source pharmaceuticals distributed through state health systems and cooperative purchasing alliances. Issuing bodies span municipal fire departments and city health procurement offices, state pharmacy benefit agencies, and multistate cooperative purchasing consortiums. The code reflects operational procurement by end-use agencies rather than centralized manufacturer relationships — city purchasing departments soliciting sealed bids for immediate use by field responders, state health commissions gathering market intelligence on direct-to-manufacturer pharmacy programs, and regional cooperative alliances establishing framework agreements with multiple awarded vendors for distribution through authorized wholesalers.

Activity concentrates in Florida and the Upper Midwest with national scope through cooperative vehicles. The City of Tampa Purchasing Department solicited Advanced Life Support Medications (IFB 26P00188, due April 8, 2026) for Tampa Fire Rescue, requiring 370 units of Labetalol HCl 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials with a $40,000 estimated contract value and one-year term plus renewal options; this procurement included a 5 percent Small Local Business Enterprise bid discount. The Minnesota Department of Administration's Office of State Procurement issued an RFP through the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) for Generic Multi Source Pharmaceuticals and OTC Products (RFP S1070000015802, due March 26, 2026) serving Minnesota, Oregon, and other participating jurisdictions, with awards effective July 1, 2026 and two-year terms. The Texas Health and Human Services Commission posted a Request for Information on direct-to-manufacturer prescription programs in early April 2026, signaling future formal procurement to establish state pharmacy benefit contracting outside traditional pharmacy benefit manager and group purchasing organization channels.